Y. Bozkaya Et Al. , "Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer," Journal of Obstetrics and Gynaecology , vol.37, no.5, pp.649-654, 2017
Bozkaya, Y. Et Al. 2017. Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer. Journal of Obstetrics and Gynaecology , vol.37, no.5 , 649-654.
Bozkaya, Y., Doğan, M., Umut Erdem, G., Tulunay, G., Uncu, H., Arık, Z., ... Demirci, U.(2017). Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer. Journal of Obstetrics and Gynaecology , vol.37, no.5, 649-654.
Bozkaya, Yakup Et Al. "Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer," Journal of Obstetrics and Gynaecology , vol.37, no.5, 649-654, 2017
Bozkaya, Yakup Et Al. "Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer." Journal of Obstetrics and Gynaecology , vol.37, no.5, pp.649-654, 2017
Bozkaya, Y. Et Al. (2017) . "Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer." Journal of Obstetrics and Gynaecology , vol.37, no.5, pp.649-654.
@article{article, author={Yakup Bozkaya Et Al. }, title={Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer}, journal={Journal of Obstetrics and Gynaecology}, year=2017, pages={649-654} }